Back to top
more

Global X Genomics & Biotechnology ETF: (GNOM)

(Delayed Data from NASDAQ) As of Jul 22, 2024 11:23 AM ET

$11.30 USD

11.3
9,785

+0.11 (1.00%)

Volume: 9,785

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

NA

ETF Quote Details

Previous Close 11.19
Open 11.28
Bid 11.26
Ask 11.28
Day Low-High 11.22-11.32
52wk Low-High 8.63-12.58
Volume 9,785
NAV (month end) 10.46
Premium (+)/Discount (-) (month end)+0.73

Zacks Premium Research for GNOM

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

 NA
ETF Risk

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

NA
ETF Snapshot

ETF Expense Ratio

Expense Ratio 0.50%
Dividend (Yield) $0.00 (0.00%)
Issuer GLOBAL X MANAGEMENT

Benchmark for GNOM

SOLACTIVE GENOMICS INDEX

The Solactive Genomics Index tracks the companies that generate revenues from gene editing, genomic sequencing, development and testing of genetic medicine/therapies, computational genomics and genetic diagnostics, and biotechnology.

Fund Summary for GNOM

GLOBAL X GENOMICS & BIOTECHNOLOGY ETF

The Global X Genomics & Biotechnology ETF seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index.